Menu
Back to Journals » Cancer Management and Research » Volume 12
The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum]
Wang Y, Lu M, Zhou Y, et al. Cancer Manag Res. 2020;12:5255–5264.
The authors have advised that there is an error in Table 1 on page 5257. The value “26.00” in the Median row for Age(years) should read “31.5”.
The authors have also advised that there is an error in Table 2 on page 5258. The column heading “Overall Survival” should read “Overall Follow-up Time”.
The authors apologize for these errors and advise it does not affect the conclusions of the paper.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.